The Embassy of Pakistan in Beijing organized two investment promotion events for Pakistan-China B2B Investment Conference on Pharmaceuticals, Biotechnology and Healthcare. These events were co-hosted with the China Overseas Development Association (CODA) and IBI Goulian Gufen designed to mobilize Chinese investors for the B2B Conference scheduled in Karachi on 17-18 July 2026.
The two events attracted nearly 60 leading Chinese enterprises, including over 40 companies led by CODA at the Embassy premises and 17 companies at the IBI event in Beijing’s Fengtai District. Participating companies represented a broad spectrum of sectors, including pharmaceuticals, biotechnology, vaccines, medical devices, diagnostics, healthcare services, digital health, clinical research, and related industries.
Addressing the participants, Ambassador of Pakistan to China, H.E. Mr. Khalil Hashmi, highlighted the growing momentum in Pakistan-China economic cooperation noting that China-Pakistan Economic Corridor (CPEC 2.0) is increasingly focused on promoting industrial cooperation, technology transfer, innovation, and value-added manufacturing, with pharmaceuticals, healthcare, and biotechnology as priority areas of collaboration.
The Ambassador informed participants that the Karachi conference forms part of the Embassy’s broader B2B investment mobilization initiative launched in 2024 to connect Chinese and Pakistani enterprises across 21 priority sectors.
